Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

NCT04838704 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

215

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: Ruxolitinib+Calcineurin inhibitor+Methotrexate
DRUG: Calcineurin Inhibitor+Methotrexate+Mycophenolate mofetil

Sponsor

Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]